ZVRA — Zevra Therapeutics, Inc. stock price, charts and financials

QT56Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
10.52
+0.46+4.57%
ZVRAQT56Zevra Therapeutics, Inc.·NASDAQ
10.52+4.57%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jun 23, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 05, 20268-KCurrent report
May 29, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 06, 2026SC 13GBeneficial ownership statement (passive)
May 06, 202610-QQuarterly report
May 06, 20268-KCurrent report
Apr 20, 2026DEF 14ADefinitive proxy statement
Apr 06, 2026PRE 14APreliminary proxy statement
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 26, 20264Statement of changes in beneficial ownership
Mar 19, 20263Initial statement of beneficial ownership
Mar 19, 20264Statement of changes in beneficial ownership
Mar 16, 20268-KCurrent report
Mar 09, 20268-KCurrent report
Mar 09, 202610-KAnnual report
Mar 09, 2026S-8Registration of employee benefit securities
Feb 10, 20264Statement of changes in beneficial ownership